Skip to main content

Peer Review reports

From: A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season

Original Submission
12 Nov 2009 Submitted Original manuscript
21 Dec 2009 Reviewed Reviewer Report - Oliver Schildgen
24 Dec 2009 Reviewed Reviewer Report - Joan Robinson
29 Dec 2009 Reviewed Reviewer Report - Cody Meissner
5 Mar 2010 Author responded Author comments - Pamela Griffin
Resubmission - Version 2
5 Mar 2010 Submitted Manuscript version 2
28 Mar 2010 Reviewed Reviewer Report - Joan Robinson
29 Mar 2010 Reviewed Reviewer Report - Cody Meissner
Resubmission - Version 3
Submitted Manuscript version 3
26 May 2010 Author responded Author comments - Pamela Griffin
Resubmission - Version 4
26 May 2010 Submitted Manuscript version 4
Publishing
3 Jun 2010 Editorially accepted
3 Jun 2010 Article published 10.1186/1471-2431-10-38

You can find further information about peer review here.

Back to article page